E
BMY icon

Ergoteles’s Bristol-Myers Squibb BMY Stock Holding History

Ergoteles’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-31,964
Closed -$2.27M – 1464
2022
Q3 		$2.27M Sell
31,964
-7,484
-19% -$543K 0.08% 248
2022
Q2 		$3.04M Buy
39,448
+12,104
+44% +$922K 0.09% 225
2022
Q1 		$2M Buy
+27,344
New +$1.84M 0.08% 257
2021
Q4 		– Sell
-18,116
Closed -$1.07M – 1254
2021
Q3 		$1.07M Sell
18,116
-253,920
-93% -$16.7M 0.04% 363
2021
Q2 		$18.2M Sell
272,036
-80,309
-23% -$5.24M 0.42% 41
2021
Q1 		$22.2M Buy
352,345
+306,318
+666% +$19.1M 0.69% 32
2020
Q4 		$2.85M Sell
46,027
-16,873
-27% -$1.04M 0.09% 209
2020
Q3 		$3.79M Buy
+62,900
New +$3.79M 0.5% 37

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Ergoteles's BMY Position: Q4 2022 in Review

Ergoteles sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 31,964 shares — an estimated $2.27M sold.

Ergoteles first reported a position in BMY in Q3 2020 and held it in 8 quarters. The position peaked at $22.2M in Q1 2021. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

  • Ergoteles reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
  • Ergoteles sold 31,964 Bristol-Myers Squibb shares in Q4 2022, an estimated $2.27M.
  • Ergoteles first reported a position in Bristol-Myers Squibb in Q3 2020 and held it in 8 quarters.
  • Ergoteles's Bristol-Myers Squibb position peaked at $22.2M in Q1 2021.
  • 2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.